Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.84 USD | +4.45% | +3.88% | -28.57% |
May. 29 | Transcript : BridgeBio Pharma, Inc. - Special Call | |
May. 28 | UBS Adjusts Price Target on BridgeBio Pharma to $47 From $51, Maintains Buy Rating | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-28.57% | 5.17B | |
-2.91% | 89.01B | |
-3.68% | 37.79B | |
-14.91% | 31.22B | |
+60.33% | 26.1B | |
-22.74% | 14.25B | |
-8.73% | 12.8B | |
-10.57% | 11.65B | |
+4.04% | 8.7B | |
-17.54% | 7.45B |
- Stock Market
- Equities
- BBIO Stock
- News BridgeBio Pharma, Inc.
- Earnings Flash (BBIO) BRIDGEBIO PHARMA Posts Q1 Revenue $211.1M